Kronox Lab Sciences Ltd. (KRONOX.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-38.0%

₹122.28

vs ₹197.10 price

Levered DCF

₹113.71

After debt service

Piotroski score

3 / 9

Weak

Altman Z-score

—

Rating

B-

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	15.32×	21.07×	27.71×	35.56×	43.41×	60.81×	75.87×
P/B	3.65×	5.99×	8.92×	13.23×	14.65×	22.05×	27.74×
P/S	4.19×	5.39×	6.58×	6.18×	7.19×	9.44×	12.7×
EV / EBITDA	10.71×	15.06×	19.69×	24.57×	28.46×	39.11×	53.32×
Gross margin	54.0%	49.2%	49.0%	42.6%	42.4%	44.6%	47.2%
Operating margin	31.8%	32.1%	30.5%	21.4%	21.8%	35.9%	37.0%
Net margin	27.3%	25.4%	23.8%	17.4%	16.6%	15.5%	16.8%
Current ratio	7.6×	7.28×	6.07×	3.89×	3.21×	3.3×	3.26×
Debt / equity	0.01×	0×	0×	0×	0.08×	0.14×	0×
Interest coverage	282.66×	0×	0×	220.44×	44.24×	0×	0×
Dividend yield	0.4%	0.3%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	6.7%	7.3%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	23.8%	28.3%	32.2%	37.2%	33.8%	36.3%	36.7%
Return on invested capital	20.3%	26.5%	30.8%	33.7%	30.1%	54.0%	58.6%
Return on assets	21.7%	25.8%	28.9%	30.8%	24.0%	25.8%	27.6%
Free cash flow yield	4.9%	5.1%	0.9%	1.9%	0.9%	1.6%	0.5%
Earnings yield	6.5%	4.7%	3.6%	2.8%	2.3%	1.6%	1.3%
Enterprise value	₹4.2B	₹5.4B	₹5.9B	₹5.9B	₹5.9B	₹5.9B	₹6.4B
Net debt / EBITDA	-0.03×	-0.09×	-0.09×	-0.15×	0.03×	0.1×	-0.06×
Cash conversion cycle (days)	90	68	112	83	85	79	81